Immunovant Inc

IMVTStocksBiotechnologyUnited StatesNasdaqUSD

Price

$34.53

Today

-7.4%

YTD

+47.0%

About

Immunovant Inc is a clinical-stage biopharmaceutical company pioneering research into autoimmune diseases. Operating globally from the US, Immunovant Inc focuses on developing innovative therapies for patients with debilitating diseases. Situated within the biotech sector, Immunovant primarily dedicates its resources to discovering innovative, patient-centric treatments. The company is currently leading research for IMVT-1402, a novel therapy for autoimmune conditions. Although independent, Immunovant Inc benefits from the guidance of Roivant Sciences, a larger healthcare sector organisation. Diversify your virtual portfolio by monitoring the IMVT share price on eToro.

Price chart

Closing price history for IMVT (1D candles).

Open positions

Current open positions for this instrument from your live portfolio.

Open positions

Unrealized return

+0.0%

No open positions exist for this instrument at the moment.

Financial insights

Valuation

P/E (TTM)-14.34

P/S (TTM)0.00

P/B (TTM)9.50

Market cap$8.15B

Cap tierMid-cap

Industry avg P/E-6.10

Profitability

Gross marginUnknown

EBIT margin0.00%

Net marginUnknown

ROE-64.82%

ROA-58.29%

Earnings & Revenue

Revenue (TTM)$0.00

Revenue growth (1Y)Unknown

EPS (TTM)-$2.77

Free cash flow$-407.32M

Total debt$72,000.00

Dividends & Risk

Dividend rate$0.00

Dividend yield0.00%

Beta (5Y)1.14

Employees315

Next earnings9 Nov '26

Trade history

Closed trades

Realized return

+0.0%

No stored closed trades exist for this instrument yet.